Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04946344 · ClinicalTrials.gov registry record · NA

The Cherokee Study: Cherokee Health for Elderly Residents With Osteoarthritis of the Knee

A NA study, sponsored by Wake Forest University.

Completed
Registry status
NA
Development phase
16
Enrollment target

NCT04946344: Completed NA study, sponsored by Wake Forest University.

NCT04946344 is a NA study that has completed, run by Wake Forest University. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04946344, a NA study, has completed, sponsored by Wake Forest University.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

This study aims to develop and demonstrate the effectiveness of a systematic, practical, cost-effective diet-induced weight loss and exercise intervention in Cherokee, North Caroling that will recruit American Indian participants; that can reduce pain and improve other clinical outcomes in knee OA patients. This pragmatic community-based trial will determine if the investigators previous findings translate to real-world settings and will address common concerns about barriers to effectiveness/ implementation.

Primary Outcome

Western Ontario McMasters Universities Osteoarthritis Index (WOMAC) pain subscale in overweight and obese adults with knee OA compared to an attention-control group - The pain index assesses participants' pain on the same scale, ranging from 0 (none) to 4 (extreme). The pain subscale consists of 5 items. Normalized values are reported. To calculate, the mean score of the individual items of is divided by 4 (the highest possible score for a single answer option). The mean of the observed items is

Interventions

  • BEHAVIORAL Attention Control
  • BEHAVIORAL Diet & Exercise

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2022-05-12
Est. Completion 2023-04-20
Phase NA
Wake Forest University

100 total trials

What the finished NCT04946344 record still lists

NCT04946344 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.

NCT04946344 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04946344 about?

NCT04946344 is a clinical study titled "The Cherokee Study: Cherokee Health for Elderly Residents With Osteoarthritis of the Knee". This study aims to develop and demonstrate the effectiveness of a systematic, practical, cost-effective diet-induced weight loss and exercise intervention in Cherokee, North Caroling that will recruit American Indian participants; that can reduce pain and improve other clinical outcomes in knee OA p...

What is the current status of trial NCT04946344?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2022-05-12. Estimated completion is 2023-04-20.

What interventions are being tested in trial NCT04946344?

The interventions under investigation include: Attention Control (BEHAVIORAL), Diet & Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT04946344?

This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04946344's enrollment target sits among peer trials

16 1871st of 2000 higher than 120 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04946344, the US trial registry maintained by the National Library of Medicine. NCT04946344 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.